钝性主动脉损伤的腔内治疗进展  

Advance in endovascular repair of blunt thoracic aortic injury

作　　者：任为[1] 李追[1] REN Wei;LI Zhui(Department of Vascular Surgery,The First Affiliated Hospital of Chongqing Medical University,Chongqing 400016,China)

机构地区：[1]重庆医科大学附属第一医院血管外科

出　　处：《创伤外科杂志》2019年第12期881-884,共4页Journal of Traumatic Surgery

摘　　要：钝性主动脉损伤(BTAI)是创伤患者的主要死因之一。为明确此疾病的规范化诊疗,本文结合2011年美国血管外科学会(SVS)及2014年美国东部创伤外科协会(EAST)为该疾病制定的诊断与治疗指南及当前的治疗进展进行综述。EAST指南强烈推荐胸部增强CT作为BTAI患者首选的诊断方式;SVS指南与EAST指南强烈推荐胸主动脉腔内修复(TEVAR)作为BTAI患者的首选治疗方式;而手术时机的选择,EAST指南则建议在强调使用控制性降压治疗的基础上,BTAI患者可延期手术治疗;但目前尚不能明确TEVAR后患者的自然病程及转归,且缺乏统一的随访策略。Blunt thoracic aortic injury(BTAI)is one of the main causes of death in trauma patients.To define the diagnosis and management of this disease,we reviewed the guidelines of diagnosis and management of BTAI from the Society for Vascular Surgery(SVS)and Eastern Association for the Surgery of Trauma(EAST)in 2011 and 2014,respectively.Computed tomography of the chest with intravenous contrast is strongly recommended to diagnose clinically significant BTAI by EAST guideline,and thoracic endovascular aortic repair(TEVAR)is strongly recommended for patients without contraindications by SVS and EAST guidelines.Delayed repair of BTAI is suggested,with the stipulation that effective blood pressure control with antihypertensive medication must be used in these patients.However,the natural history and long-term outcome of TEVAR and optimal strategy for follow-up are still unknown.

关 键 词：钝性主动脉损伤 腔内修复 指南 

分 类 号：R654.2[医药卫生—外科学]